nitromethaqualone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nitromethaqualone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	63339
SCHEMBL ID	16334540
MeSH ID	M0060694

Synonyms (23)

Synonym
nitromethaqualone
4(3h)-quinazolinone, 2-methyl-3-(4-nitro-o-anisyl)-
2-methyl-3-(2-methoxy-4-nitrophenyl)quinazolin-4-one
2-methyl-3-(2-methoxy-4-nitrophenyl)chinazolon-4 [german]
4(3h)-quinazolinone, 3-(2-methoxy-4-nitrophenyl)-2-methyl-
nitrometaqualone
chi 26
parnox
brn 0897371
3-(2-methoxy-4-nitrophenyl)-2-methylquinazolin-4-one
7g855468zm ,
5-24-03-00145 (beilstein handbook reference)
340-52-3
unii-7g855468zm
2-methyl-3-(2-methoxy-4-nitrophenyl)chinazolon-4
SCHEMBL16334540
RZHHDMJWDYJXAW-UHFFFAOYSA-N
3-(2-methoxy-4-nitrophenyl)-2-methyl-4(3h)-quinazolinone #
DTXSID80187601
2-methyl-3-(o-methoxy-p-nitrophenyl)-4-quinazolone
2-methyl-3-(2-methoxy-4-nitrophenyl)-4(3h)-quinazolinone
4(1h)-quinazolinone, 3-(2-methoxy-4-nitrophenyl)-2-methyl-
Q7041485

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	5 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	40.89 (24.57)
Research Supply Index	1.79 (2.92)
Research Growth Index	4.45 (4.65)
Search Engine Demand Index	56.46 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (40.89)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	5 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
methaqualone Methaqualone: A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604). methaqualone : A member of the class of quinazolines that is quinazolin-4-one substituted at positions 2 and 3 by methyl and o-tolyl groups respectively. A depressant that increases the activity of the GABA receptors in the brain and nervous system, it is used as a sedative and hypnotic medication. It became popular as a recreational drug and club drug in the late 1960s and 1970s.	3.04	5	0	quinazolines	GABA agonist; sedative
nitrophenols Nitrophenols: PHENOLS carrying nitro group substituents.	3.04	5	0

Condition	Relationship Strength	Studies
Dyskinesia Syndromes [description not available]	1.93	1
Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.	1.93	1
Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.	1.93	1
Behavior Disorders [description not available]	1.94	1
Psychoses [description not available]	1.94	1
Neuroses [description not available]	1.94	1
Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.	1.94	1
Neurotic Disorders Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.	1.94	1
Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)	1.94	1

chemdatabank.com